Poseida Therapeutics, Inc. (PSTX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Poseida Therapeutics, Inc. (PSTX)
Company Performance

Current Price

as of Oct 18, 2024

$2.45

P/E Ratio

N/A

Market Cap

$237.98M

Description

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Metrics

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerPSTX
  • Price$2.45-3.54%

Trading Information

  • Market Cap$237.98M
  • Float67.00%
  • Average Daily Volume (1m)543,387
  • Average Daily Volume (3m)466,682
  • EPS-$1.19

Company

  • Revenue$88.46M
  • Rev Growth (1yr)29.78%
  • Net Income-$31.37M
  • Gross Margin94.81%
  • EBITDA Margin-117.07%
  • EBITDA-$30.41M
  • EV$128.98M
  • EV/Revenue1.46
  • P/EN/A
  • P/S2.69
  • P/B3.91
Documents